Ovarian hormones and the heterogeneous receptor mechanisms mediating the discriminative stimulus effects of ethanol in female rats

Behav Pharmacol. 2013 Apr;24(2):95-104. doi: 10.1097/FBP.0b013e32835efc5f.

Abstract

Past studies have suggested that progesterone-derived ovarian hormones contribute to the discriminative stimulus effects of ethanol, particularly via progesterone metabolites that act at γ-aminobutyric acid type A (GABA(A)) receptors. It is unknown whether loss of ovarian hormones in women, for example, after menopause, may be associated with altered receptor mediation of the effects of ethanol. The current study measured the substitution of allopregnanolone, pregnanolone, pentobarbital, midazolam, dizocilpine, TFMPP, and RU 24969 in female sham and ovariectomized rats trained to discriminate 1.0 g/kg ethanol from water. The groups did not differ in the substitution of GABA(A)-positive modulators (barbiturates, benzodiazepines, neuroactive steroids) or the N-methyl-D-aspartate receptor antagonist dizocilpine. Similarly, blood-ethanol concentration did not differ between the groups, and plasma adrenocorticotropic hormone, progesterone, pregnenolone, and deoxycorticosterone were unchanged 30 min after administration of 1.0 g/kg ethanol or water. However, substitution of neuroactive steroids and RU 24969, a 5-hydroxytryptamine (5-HT)(1A/1B) receptor agonist, was lower than observed in previous studies of male rats, and TFMPP substitution was decreased in ovariectomized rats. Ovarian hormones appear to contribute to 5-HT receptor mediation of the discriminative stimulus effects of ethanol in rats.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alcohol Deterrents / therapeutic use
  • Alcohol Drinking / adverse effects*
  • Alcohol Drinking / blood
  • Alcohol Drinking / metabolism
  • Alcohol Drinking / prevention & control
  • Animals
  • Behavior, Animal / drug effects
  • Discrimination Learning / drug effects*
  • Drug Resistance
  • Estrous Cycle / blood
  • Estrous Cycle / metabolism*
  • Ethanol / blood
  • Female
  • Hormone Replacement Therapy
  • Neurotransmitter Agents / blood
  • Neurotransmitter Agents / pharmacokinetics
  • Neurotransmitter Agents / therapeutic use
  • Ovariectomy / adverse effects
  • Ovary / drug effects
  • Ovary / metabolism
  • Ovary / physiology*
  • Postmenopause / blood
  • Postmenopause / metabolism*
  • Progesterone / analogs & derivatives*
  • Progesterone / blood
  • Progesterone / pharmacokinetics
  • Progesterone / therapeutic use
  • Rats
  • Rats, Long-Evans
  • Receptors, Neurotransmitter / agonists
  • Receptors, Neurotransmitter / antagonists & inhibitors
  • Receptors, Neurotransmitter / metabolism
  • Receptors, Progesterone / agonists
  • Receptors, Progesterone / antagonists & inhibitors
  • Receptors, Progesterone / metabolism*
  • Serotonin Receptor Agonists / blood
  • Serotonin Receptor Agonists / pharmacokinetics
  • Serotonin Receptor Agonists / therapeutic use

Substances

  • Alcohol Deterrents
  • Neurotransmitter Agents
  • Receptors, Neurotransmitter
  • Receptors, Progesterone
  • Serotonin Receptor Agonists
  • Ethanol
  • Progesterone